A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia

  • Franziska Hörbrand, Peter Bramlage, Johann Fischaleck, Joerg Hasford, Reinhard Brunkhorst
  • European Journal of Clinical Pharmacology, October 2012, Springer Science + Business Media
  • DOI: 10.1007/s00228-012-1412-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00228-012-1412-5

The following have contributed to this page: Peter Bramlage